Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ORLY vs GSK✓SelectedUSD · GSKORLY vs GSK performance historyLatest closeAs of+0.73%11/18
Stock and ETF performance explorer

ORLY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+427.0%
GSK return
+101.2%
Excess return
+325.9%
Maximum drawdown
-42.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.7%-1.3%+2.1%+1.2%
7D+3.1%-3.1%+6.3%+4.2%
30D+4.8%-0.9%+5.7%+5.0%
3M+2.9%-4.2%+7.0%+4.1%
6M+1.8%-1.6%+3.4%+1.9%
YTD+2.4%+2.6%-0.2%+0.3%
1Y-5.0%+6.2%-11.3%-8.1%
3Y+44.6%+55.0%-10.4%+17.5%
5Y+116.8%+42.8%+74.0%+78.3%
10Y+427.0%+102.1%+324.9%+262.7%
All+427.0%+101.2%+325.9%+262.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling